Latest Product News
Medical Device Components That Inhibit Bacterial Growth
Vyon® porous plastics from Porvair Sciences are the perfect material for filtration applications in the healthcare and medical device market.
Biosynth Carbosynth, Vivitide and Pepscan Rebrand to Biosynth
Biosynth Carbosynth, vivitide and Pepscan are pleased to announce today their rebranding to Biosynth to match their parent group.
Genome Editing of Immune Cells
On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery.
Takara Bio Announces Partnership for the Distribution of CE-IVD Solutions for Respiratory Tract Infections
Takara Bio Europe announced today a partnership with the German company BioeXsen GmbH for the distribution of in vitro diagnostic solutions for the qPCR detection of common pathogens found in respiratory tract infections.
Cherwell Supports PHSS Annual Conference 2022
Cherwell Laboratories has confirmed its continued support for the Pharmaceutical & Healthcare Sciences Society (PHSS) Annual Conference 2022.
Bio-Rad Introduces Anti-Evolocumab Antibodies for Use in Preclinical and Clinical Drug Development
Bio-Rad Laboratories, Inc. has introduced a range of type 1 antibodies that inhibit the binding of evolocumab to its target, human proprotein convertase subtilisin/kexin type 9, a protein that has been shown to play a key role in the regulation of cholesterol levels.
Bio-Rad Extends Range of StarBright Violet and UltraViolet Dyes for Multiplex Flow Cytometry
Bio-Rad Laboratories, Inc. has extended its range of StarBright Dyes to provide greater flexibility in multicolor flow cytometry panels.
The New Nebula® Multimode Reader from Lonza Streamlines Quantitative Endotoxin Detection
Lonza has launched the Nebula® Multimode Reader, the first multimode reader qualified for use with Lonza’s turbidimetric, chromogenic and recombinant endotoxin detection methods.
Jackson ImmunoResearch Anti-Human IgE Antibodies
Jackson ImmunoResearch announces a new addition to its range of products for scientists developing immunoassays for the serology and diagnostics markets.
Biosynth Carbosynth To Offer Enzyme Development Following Acquisition of EUCODIS Bioscience
Biosynth Carbosynth announces today that it has signed an agreement to acquire EUCODIS Bioscience.